Skip to Main Content

Author Details

David A Wheeler
Baylor College of Medicine
1984
179
92
PMIDPaper TitleJournal TitlePublished Year
36829160Detection and characterization of constitutive replication origins defined by DNA polymerase epsilon.BMC Biol2023
36829160Detection and characterization of constitutive replication origins defined by DNA polymerase epsilon.BMC Biol2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36697836Author Correction: The repertoire of mutational signatures in human cancer.Nature2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
36697836Author Correction: The repertoire of mutational signatures in human cancer.Nature2023
36002187Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response.J Immunother Cancer2022
36002187Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response.J Immunother Cancer2022
35351983RNAseqCNV: analysis of large-scale copy number variations from RNA-seq data.Leukemia2022
35349735Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.Hepatology2022
35351983RNAseqCNV: analysis of large-scale copy number variations from RNA-seq data.Leukemia2022
35349735Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.Hepatology2022
32339229The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.J Natl Cancer Inst2021
32339229The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.J Natl Cancer Inst2021
34120183A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.J Clin Endocrinol Metab2021
34147031Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.J Clin Endocrinol Metab2021
34301788Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.Cancer Discov2021
33217343Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.Cancer Cell2021
32603507The Proximal Airway Is a Reservoir for Adaptive Immunologic Memory in Idiopathic Subglottic Stenosis.Laryngoscope2021
34301788Genomes for Kids: The Scope of Pathogenic Mutations in Pediatric Cancer Revealed by Comprehensive DNA and RNA Sequencing.Cancer Discov2021
34120183A High-throughput Approach to Identify Effective Systemic Agents for the Treatment of Anaplastic Thyroid Carcinoma.J Clin Endocrinol Metab2021
34147031Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity.J Clin Endocrinol Metab2021
33217343Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.Cancer Cell2021
32603507The Proximal Airway Is a Reservoir for Adaptive Immunologic Memory in Idiopathic Subglottic Stenosis.Laryngoscope2021
32641413Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.Cancer Res2020
32025018The repertoire of mutational signatures in human cancer.Nature2020
32641413Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.Cancer Res2020
32686686Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival.Nat Commun2020
32949309Identification of novel fusion transcripts in meningioma.J Neurooncol2020
32025018The repertoire of mutational signatures in human cancer.Nature2020
32686686Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival.Nat Commun2020
32949309Identification of novel fusion transcripts in meningioma.J Neurooncol2020
30302893Framework for microRNA variant annotation and prioritization using human population and disease datasets.Hum Mutat2019
31693904Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.Cell Rep2019
30302893Framework for microRNA variant annotation and prioritization using human population and disease datasets.Hum Mutat2019
31509758Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019
31416464An enhanced genetic model of colorectal cancer progression history.Genome Biol2019
31365877Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019
31693904Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design.Cell Rep2019
31416464An enhanced genetic model of colorectal cancer progression history.Genome Biol2019
31509758Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019
31365877Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.Cell Rep2019
28918914Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.Gastroenterology2018
28918914Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.Gastroenterology2018
30221071Gene expression profiling and immune cell-type deconvolution highlight robust disease progression and survival markers in multiple cohorts of CTCL patients.Oncoimmunology2018
29981437Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer.J Thorac Oncol2018
29925010The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
29920119National Cancer Institute Biospecimen Evidence-Based Practices: Harmonizing Procedures for Nucleic Acid Extraction from Formalin-Fixed, Paraffin-Embedded Tissue.Biopreserv Biobank2018
30096302Comprehensive Characterization of Cancer Driver Genes and Mutations.Cell2018
29898407Integrated Molecular Characterization of Testicular Germ Cell Tumors.Cell Rep2018
  • 1 - 50 of 358

Recommended Authors

Sebastian M Waszak
University of California san francisco
Career Start Year 2010
Number of shared co-authors 56
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year 2008
Number of shared co-authors 31
Martin R Jones
BC Cancer Research Centre.
Career Start Year 2007
Number of shared co-authors 25
Nicolas Robine
Sloan-Kettering Institute
Career Start Year 2006
Number of shared co-authors 41
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 54
Yongjun Zhao
Canada British Columbia Cancer Research Centre, University of British Columbia
Career Start Year 2005
Number of shared co-authors 89
Robert Huether
Division of Clinical Genomics
Career Start Year 2005
Number of shared co-authors 43
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 18
Jianmin Wang
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 10
Peter Van Loo
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 55
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 63
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 48
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 24
Philip C Zuzarte
Ontario Institute for Cancer Research
Career Start Year 2000
Number of shared co-authors 22
Shawn Levy
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 66
Ru-Fang Yeh
Genentech Inc.
Career Start Year 1999
Number of shared co-authors 110
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Career Start Year 1999
Number of shared co-authors 47
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 8
Sarah J Wheelan
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 36
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 10
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 25
Jay Shendure
University of Washington
Career Start Year 1996
Number of shared co-authors 86
Sean McGrath
Harvard T.H. Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 40
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 18
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 27
Samuel Aparicio
University of British Columbia
Career Start Year 1993
Number of shared co-authors 45
Glenn S Cowley
Broad Institute of Harvard and MIT
Career Start Year 1990
Number of shared co-authors 24
Shrikant Mane
Yale School of Medicine
Career Start Year 1989
Number of shared co-authors 44
Jiannis Ragoussis
McGill University
Career Start Year 1986
Number of shared co-authors 39
Peter K Rogan
CytoGnomix Inc.
Career Start Year 1981
Number of shared co-authors 2

Collaborators

Richard A Gibbs
Baylor College of Medicine
Co-authored papers 75
Donna M Muzny
Baylor College of Medicine
Co-authored papers 62
Harshavardhan Doddapaneni
Baylor College of Medicine
Co-authored papers 20
George M Weinstock
The Genome Center at Washington University, Washington University School of Medicine
Co-authored papers 19
Kyle R Covington
Baylor College of Medicine
Co-authored papers 19
Lora R Lewis
Baylor College of Medicine
Co-authored papers 18
Kim C Worley
Baylor College of Medicine
Co-authored papers 17
Linghua Wang
The University of Texas M. D. Anderson
Co-authored papers 17
Sharon E Plon
Baylor College of Medicine
Co-authored papers 16
Eve Shinbrot
Baylor College of Medicine
Co-authored papers 15
Rehan Akbani
The University of Texas MD Anderson Cancer Center
Co-authored papers 15
Margaret B Morgan
Baylor College of Medicine
Co-authored papers 14
Lynne V Nazareth
Baylor College of Medicine
Co-authored papers 12
Erica Sodergren
The Genome Institute at Washington University
Co-authored papers 12
Steven E Scherer
Baylor College of Medicine
Co-authored papers 11
Chad J Creighton
Co-authored papers 11
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Co-authored papers 11
Alicia Hawes
Regeneron Pharmaceuticals Inc.
Co-authored papers 11
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 10
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers 10
Huyen Dinh
Institute of Advanced Energy, Kyoto University
Co-authored papers 10
Xi Liu
College of Biology and Food, Shangqiu Normal University
Co-authored papers 10
Lawrence A Donehower
Baylor College of Medicine
Co-authored papers 10
Shannon Dugan
Baylor College of Medicine
Co-authored papers 9
Richard K Wilson
The Ohio State University
Co-authored papers 9
Donald W Parsons
Texas Children's Hospital
Co-authored papers 9
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 9
David Steffen
Co-authored papers 9
Xingzhi Song
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers 8
Release 1.2